Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
J Biol Chem. 2020 Jul 10;295(28):9531-9541. doi: 10.1074/jbc.RA120.013354. Epub 2020 May 18.
Human leukocyte immunoglobulin-like receptors (LILRs) typically regulate immune activation by binding to the human leukocyte antigen class I molecules. LILRA2, a member of the LILR family, was recently reported to bind to other unique ligands, the bacterially degraded Igs (N-truncated Igs), for the activation of immune cells. Therefore, LILRA2 is currently attracting significant attention as a novel innate immune receptor. However, the detailed recognition mechanisms required for this interaction remain unclear. In this study, using several biophysical techniques, we uncovered the molecular mechanism of N-truncated Ig recognition by LILRA2. Surface plasmon resonance analysis disclosed that LILRA2 specifically binds to N-truncated Ig with weak affinity ( = 4.8 μm) and fast kinetics. However, immobilized LILRA2 exhibited a significantly enhanced interaction with N-truncated Ig due to avidity effects. This suggests that cell surface-bound LILRA2 rapidly monitors and identifies bi- or multivalent abnormal N-truncated Igs through specific cross-linking to induce immune activation. Van't Hoff analysis revealed that this interaction is enthalpy-driven, with a small entropy loss, and results from differential scanning calorimetry indicated the instability of the putative LILRA2-binding site, the Fab region of the N-truncated Ig. Atomic force microscopy revealed that N truncation does not cause significant structural changes in Ig. Furthermore, mutagenesis analysis identified the hydrophobic region of LILRA2 domain 2 as the N-truncated Ig-binding site, representing a novel ligand-binding site for the LILR family. These results provide detailed insights into the molecular regulation of LILR-mediated immune responses targeting ligands that have been modified by bacteria.
人类白细胞免疫球蛋白样受体(LILR)通常通过与人类白细胞抗原 I 类分子结合来调节免疫激活。LILRA2 是 LILR 家族的成员,最近有报道称其与其他独特的配体(细菌降解的 Ig,N 端截断的 Ig)结合,从而激活免疫细胞。因此,LILRA2 目前作为一种新型先天免疫受体受到了极大的关注。然而,这种相互作用所需的详细识别机制尚不清楚。在这项研究中,我们使用几种生物物理技术揭示了 LILRA2 识别 N 端截断 Ig 的分子机制。表面等离子体共振分析显示,LILRA2 特异性地以弱亲和力(=4.8 μm)和快速动力学与 N 端截断 Ig 结合。然而,由于亲合力效应,固定化的 LILRA2 与 N 端截断 Ig 的相互作用显著增强。这表明细胞表面结合的 LILRA2 通过特异性交联快速监测和识别二价或多价异常 N 端截断 Ig,从而诱导免疫激活。范特霍夫分析表明,这种相互作用是由焓驱动的,熵损失较小,差示扫描量热法的结果表明,假定的 LILRA2 结合位点,即 N 端截断 Ig 的 Fab 区域不稳定。原子力显微镜显示,Ig 的 N 端截断不会导致结构发生显著变化。此外,突变分析确定了 LILRA2 结构域 2 的疏水区为 N 端截断 Ig 的结合位点,代表了 LILR 家族的一个新的配体结合位点。这些结果提供了详细的见解,了解了针对细菌修饰配体的 LILR 介导的免疫反应的分子调节。